2014

Established Tianjin Sequencing Center and built a large-scale sequencing platform.

Obtained the ‘China Medical Institution’ License, the ‘China Medical Device Manufactures’ License, and ‘Laboratory Accreditation for Gene Amplification’. Grew our clinical services.

Established Novogene Corporation Inc. & Novogene (UK) Company Ltd., forming a model for our global operations.